2 From the Viewpoint of Investigators for Global Studies in the Field of Cardiology(Clinical Trials in Global Era,Roundtable Discussion 2 (RT-2) (H),The 73rd Annual Scientific Meeting of The Japanese Circulation Society)

スポンサーリンク

概要

著者

関連論文

Sex-Related Differences in the Risk Factor Profile and Medications of Patients With Atrial Fibrillation Recruited in J-TRACE
The Incidence of Ischemic Stroke : Paroxysmal Af vs Persistent/Permanent Af
2 From the Viewpoint of Investigators for Global Studies in the Field of Cardiology(Clinical Trials in Global Era,Roundtable Discussion 2 (RT-2) (H),The 73rd Annual Scientific Meeting of The Japanese Circulation Society)
Guidelines for Pharmacotherapy of Atrial Fibrillation (JCS 2008) : Digest Version
Antithrombotic Therapy in Atrial Fibrillation : Evaluation and Positioning of New Oral Anticoagulant Agents
Daily CT Measurement of Needle Applicator Displacement during Multifractionated High-dose-rate Interstitial Brachytherapy for Postoperative Recurrent Uterine Cancer
Rivaroxaban vs. Warfarin in Japanese Patients With Atrial Fibrillation : The J-ROCKET AF Study
Safety and Efficacy of Adjusted Dose of Rivaroxaban in Japanese Patients With Non-Valvular Atrial Fibrillation : – Subanalysis of J-ROCKET AF for Patients With Moderate Renal Impairment –
Target International Normalized Ratio Values for Preventing Thromboembolic and Hemorrhagic Events in Japanese Patients With Non-Valvular Atrial Fibrillation:– Results of the J-RHYTHM Registry –
Safety and Efficacy of Adjusted Dose of Rivaroxaban in Japanese Patients With Non-Valvular Atrial Fibrillation : Subanalysis of J-ROCKET AF for Patients With Moderate Renal Impairment
Target International Normalized Ratio Values for Preventing Thromboembolic and Hemorrhagic Events in Japanese Patients With Non-Valvular Atrial Fibrillation : Results of the J-RHYTHM Registry

もっと見る

スポンサーリンク